Michael Lane - 18 Nov 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

SEC form
4
Accepted by SEC
20 Nov 2026, 17:00:12 UTC
Prior SEC filing
05 Nov 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Michael Lane filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 20 Nov 2026.

Key facts

  • This page summarizes Michael Lane's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 20 Nov 2026, 17:00.

Change

  • Previous filing in this sequence was filed on 05 Nov 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001740689 Primary reporting owner

Lane Michael

Relationship
Executive Vice President

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Options Exercise

Transaction value
Shares
+483
Change %
+12%
Price
$206.94*
Shares after
4,559
Date
18 Nov 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
Shares
+183
Change %
+4%
Price
$544.08*
Shares after
4,742
Date
18 Nov 2026
Ownership
Direct
IDXX transaction

Common Stock

Options Exercise

Transaction value
Shares
+197
Change %
+4.2%
Price
$505.53*
Shares after
4,939
Date
18 Nov 2026
Ownership
Direct
IDXX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
592
Date
18 Nov 2026
Ownership
by spouse
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares
-483
Change %
-100%
Price
$0.000000*
Shares after
0
Date
18 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
483
Exercise price
$206.94
Footnotes
F2
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares
-183
Change %
-100%
Price
$0.000000*
Shares after
0
Date
18 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
183
Exercise price
$544.08
Footnotes
F3
IDXX transaction Derivative

Incentive Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares
-197
Change %
-100%
Price
$0.000000*
Shares after
0
Date
18 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
197
Exercise price
$505.53
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.

Footnote F2

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2024

Footnote F3

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2025.

Footnote F4

Grant of option to buy shares of Issuer common stock that vested in one installment on February 14, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .